GC Rieber VivoMega is partnering with OmegaQuant to offer free Omega-3 Index testing at its booth (#3552) during SupplySide West/Fi North America taking place on October 25-26.
GC Rieber VivoMega (Kristiansund, Norway) has announced a partnership with OmegaQuant to offer free Omega-3 Index testing at its booth (#3552) during SupplySide West/Fi North America taking place on October 25-26. The Omega-3 Index is the amount of EPA and DHA in the blood, with an Omega-3 Index of 8% or higher representing the ideal. According to OmegaQuant, most people’s Omega-3 Index is about 6% or lower, but in the U.S. levels of Omega-3 Index are typically 4% or lower.
“We are always thrilled to partner with companies like GC Rieber VivoMega to promote improved health and education around omega-3s,” said Jason Polreis, CEO of OmegaQuant, in a press release. “We hope to see many attendees take advantage of this great opportunity that GC Rieber VivoMega is providing.”
Attendees will also receive samples of the company’s omega-3 concentrates and a follow-up test to measure improvements in Omega-3 Index. This represents a greater than $200 value, says GC Rieber VivoMega. The company also announced that it will be showcasing its Phase II: VivoMega Platinum Sampling Program, which offers its highest concentrations in smaller dosage formats. GC Rieber VivoMega will also be showcasing and sampling its high-concentration vegan Omega-3 from microalgae.
“We want to make a big splash as SSW this year to show our ongoing commitment to excellence. Partnering with OmegaQuant to provide these Omega-3 Index tests, followed by a sample of our products and a second Omega-3 Index test, will show attendees how our products help improve omega-3 levels,” said Christopher Hachey, U.S. Business Development manager at GC Rieber VivoMega, in a press release. "Please join us at the show to learn more about our vegan and marine-derived omega-3 concentrates and our commitment to the industry through sustainable, environmentally friendly practices and human and social development."
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.